Loading clinical trials...
Loading clinical trials...
A Multicenter, Low-Interventional Study to Evaluate the Feasibility of a Prospective Clinicogenomic Program
Conditions
Interventions
Blood Draw
Locations
23
United States
Alabama Oncology
Birmingham, Alabama, United States
Clearview Cancer Institute
Huntsville, Alabama, United States
Ironwood Cancer & Research Centers
Chandler, Arizona, United States
Yale University
New Haven, Connecticut, United States
Florida Cancer Specialists; Department of Oncology
Fort Myers, Florida, United States
Florida Cancer Specialist, North Region
St. Petersburg, Florida, United States
Start Date
December 13, 2019
Primary Completion Date
November 30, 2023
Completion Date
November 30, 2023
Last Updated
January 17, 2024
NCT06476808
NCT07361497
NCT07510724
NCT06305754
NCT05920356
NCT06128551
Lead Sponsor
Genentech, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions